The Newsroom
Item 1 of 3

AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
Item 2 of 3

Historic telesurgery connects Central Florida and Angola in world-first medical breakthrough
Item 3 of 3

New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Recent Stories at AdventHealthMD
No Results
We were unable to find any results based on your search criteria.
Suggestions:
- Try removing filters.
- Try different keywords.
- Check your spelling.